☰

Erica D. Pratt, Ph.D. - Publications

Affiliations: 
2008-2015 Biomedical Engineering Cornell University, Ithaca, NY, United States 
Area:
liquid biopsy, noninvasive cancer assays, microfluidics, dPCR, post-translational modifications, peptide engineering
Tree Info Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Widstrom NE, Perez M, Pratt ED, Heier JL, Blankenhorn JF, Breidenbach L, Peterson H, Parker LL. Novel Bruton's Tyrosine Kinase (BTK) Substrates for Time-Resolved Luminescence Assays. Acs Chemical Biology. 17: 1328-1333. PMID 35653784 DOI: 10.1021/acschembio.2c00106  0.478
2020 Jena S, Damayanti NP, Tan J, Pratt ED, Irudayaraj JMK, Parker LL. Multiplexable fluorescence lifetime imaging (FLIM) probes for Abl and Src-family kinases. Chemical Communications (Cambridge, England). PMID 33035286 DOI: 10.1039/d0cc05030j  0.472
2017 Antonarakis ES, Tagawa ST, Galletti G, Worroll D, Ballman K, Vanhuyse M, Sonpavde G, North S, Albany C, Tsao CK, Stewart J, Zaher A, Szatrowski T, Zhou W, Gjyrezi A, ... ... Pratt ED, et al. Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017724138. PMID 28632486 DOI: 10.1200/Jco.2017.72.4138  0.428
2015 Tagawa ST, Galletti G, Antonarakis ES, Tasaki S, Gjyrezi A, Worroll D, Portella L, Kirby BJ, Stewart J, Zaher A, Saad F, Vanhuyse M, Suri S, Lannin TB, Gruber C, ... Pratt E, et al. Baseline analysis of circulating tumor cell (CTC) enumeration and androgen receptor (AR) localization in men with metastatic castration-resistant prostate cancer (mCRPC) in TAXYNERGY. Journal of Clinical Oncology. 33: 5031-5031. DOI: 10.1200/Jco.2015.33.15_Suppl.5031  0.337
2015 Tagawa S, Galletti G, Antonarakis E, Tasaki S, Gjyrezi A, Worroll D, Portella L, Kirby B, Stewart J, Zaher A, Saad F, Vanhuyse M, Suri S, Lannin T, Gruber C, ... Pratt E, et al. 2563 Screening and baseline analysis of circulating tumor cell (CTC) counts and androgen receptor (AR) localization with clinical characteristics of men with metastatic castration-resistant prostate cancer (mCRPC) in TAXYNERGY European Journal of Cancer. 51: S498-S499. DOI: 10.1016/S0959-8049(16)31382-X  0.339
2014 Pratt ED, Stepansky A, Hicks J, Kirby BJ. Single-cell copy number analysis of prostate cancer cells captured with geometrically enhanced differential immunocapture microdevices. Analytical Chemistry. 86: 11013-7. PMID 25363873 DOI: 10.1021/Ac503453V  0.504
2012 Kirby BJ, Jodari M, Loftus MS, Gakhar G, Pratt ED, Chanel-Vos C, Gleghorn JP, Santana SM, Liu H, Smith JP, Navarro VN, Tagawa ST, Bander NH, Nanus DM, Giannakakou P. Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device. Plos One. 7: e35976. PMID 22558290 DOI: 10.1371/Journal.Pone.0035976  0.518
2012 Kirby BJ, Jodari M, Loftus MS, Gakhar G, Pratt ED, Chanel-Vos C, Gleghorn JP, Santana SM, Liu H, Smith JP, Navarro VN, Tagawa ST, Bander NH, Nanus DM, Giannakakou P. Correction: Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device Plos One. 7. DOI: 10.1371/annotation/9d3d22ed-dc5a-4484-9254-1584864f4aac  0.358
2011 Jodari M, Loftus M, Gleghorn J, Gakhar G, Pratt E, Tagawa ST, Bander NH, Giannakakou P, Kirby B, Nanus DM. Capture and analysis of prostate cancer circulating tumor cells (CTCS) using geometrically enhanced differential immunocapture (GEDI). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 53. PMID 27968401 DOI: 10.1200/Jco.2011.29.7_Suppl.53  0.368
2011 Pratt ED, Huang C, Hawkins BG, Gleghorn JP, Kirby BJ. Rare Cell Capture in Microfluidic Devices. Chemical Engineering Science. 66: 1508-1522. PMID 21532971 DOI: 10.1016/J.Ces.2010.09.012  0.454
2011 Loftus M, Jodari-Karimi M, Gakhar G, Pratt E, Santana S, Rubin M, Bander N, Navarro V, Tagawa S, Kirby B, Nanus D, Giannakakou P. Abstract 4891: Molecular and functional analysis of circulating tumor cells in castrate resistant prostate cancer using a geometrically enhanced microfluidic device based on PSMA immunocapture Cancer Research. 71: 4891-4891. DOI: 10.1158/1538-7445.Am2011-4891  0.396
2010 Gleghorn JP, Pratt ED, Denning D, Liu H, Bander NH, Tagawa ST, Nanus DM, Giannakakou PA, Kirby BJ. Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody. Lab On a Chip. 10: 27-9. PMID 20024046 DOI: 10.1039/B917959C  0.468
2010 Loftus M, Gleghorn J, Pratt E, Bander N, Nanus D, Kirby B, Giannakakou P. Abstract 1145: Analysis of circulating tumor cells from castrate resistant prostate cancer patients captured via a microfluidic device using the prostate specific membrane antigen antibody Cancer Research. 70: 1145-1145. DOI: 10.1158/1538-7445.Am10-1145  0.414
Show low-probability matches.